BP BALKAN PHARMACEUTICALS - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 79272941
Serial Number
79272941
Registration Number
6166331
Word Mark
BP BALKAN PHARMACEUTICALS
Status
700 - Registered
Status Date
2020-10-06
Filing Date
2019-10-01
Registration Number
6166331
Registration Date
2020-10-06
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
260129, 261709 - Helixes. Curved line(s), band(s) or bar(s).
Published for Opposition Date
2020-07-21
Attorney Name
Law Office Assigned Location Code
M20
Employee Name
SEVERSON, JUSTIN
Statements
Indication of Colors claimed
The color(s) white and blue is/are claimed as a feature of the mark.
Desription of the Colors Claimed
Blue: all the verbal and figurative elements; white: background
Disclaimer with Predetermined Text
"BALKAN PHARMACEUTICALS"
Description of Mark
The mark consists of the letters "BP" with a vertical curved band between the letters, all in blue, to the left of a blue double helix design. Below the letters and design is the wording "BALKAN PHARMACEUTICALS" in blue letters. All on a white background.
Goods and Services
Pharmaceutical, medical and veterinary products, namely, products for treating digestive maladies and for affecting metabolism namely, antacids, antiulcerous preparations, antiflatulence preparations; antispastics, anticolinergics, antipropulsives; antivomitive and antinauseants, antidiarrheals; digestive aids, namely, food enzyme and dietary supplements; metabolic aids, namely, stanozolol, methandienone, mesterolone, oxandrolone and nandrolone; products for treating the liver, namely, lipotropics; products for treating disorders and illnesses of blood, haematopoetic organs- and the heparin group, namely, platelet antiaggregants; products for treating disorders and illnesses of the cardiovascular system and for providing heart therapy, namely, diuretics, peripherical vasodilators; blockers, namely, bisoprolol, pantoprazole, famotidine and naltrexone; products that act on the renin-angiotensin system, namely, ramipril, lizinopril, enalapril and captoprile; pharmaceuticals, namely, lipid lowering agents; genital-urinary system and sexual hormones, sexual and modulator hormones of the genital system, genital system medications; systemic hormonal preparations; antiinfectious products for systemic use, namely, ofloxacine, metronidazole, acyclovir, amoxaciline and furaciline; antineoplastic agents and immunomodulators; products for treating the skeletal muscle system, namely, antiinflammatory and antirheumatic non-steroids; products for treating the nervous system, namely, anesthetics, anticonvulsants, antiemetics, antiparkinson agents, CNS stimulants, muscle relaxants, narcotic analgesics, nonnarcotic analgesics, and sedatives; antiparasitics; products for treating the breathing pathway, namely, antiasthmatics, systemic antihistamines; sanitary products for medical use, namely, absorbent products for personal health care and hygiene, medical disinfectant liquids, wipes, sprays and soaps
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2019-12-02
Primary Code
005
Current Trademark Owners
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Bruce S. Londa
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1500717
International Registration Date
2019-10-01
International Publication Date
2019-11-28
International Renewal Date
2029-10-01
Auto Protection Date
2021-05-28
International Status
001 - Request for extension of protection established
International Status Date
2019-11-28
Priority Claimed In
True
Priority Claimed Date
2019-07-16
First Refusal In
True
Trademark Events
Event DateEvent Description
2019-11-28SN ASSIGNED FOR SECT 66A APPL FROM IB
2019-12-02NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2019-12-06APPLICATION FILING RECEIPT MAILED
2020-01-03ASSIGNED TO EXAMINER
2020-01-10NON-FINAL ACTION WRITTEN
2020-01-10NON-FINAL ACTION WRITTEN
2020-01-11NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2020-02-05REFUSAL PROCESSED BY MPU
2020-02-05NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2020-02-22REFUSAL PROCESSED BY IB
2020-03-26TEAS RESPONSE TO OFFICE ACTION RECEIVED
2020-03-26CORRESPONDENCE RECEIVED IN LAW OFFICE
2020-03-26TEAS/EMAIL CORRESPONDENCE ENTERED
2020-04-24NON-FINAL ACTION WRITTEN
2020-04-24NON-FINAL ACTION E-MAILED
2020-04-24NOTIFICATION OF NON-FINAL ACTION E-MAILED
2020-05-19TEAS RESPONSE TO OFFICE ACTION RECEIVED
2020-05-19CORRESPONDENCE RECEIVED IN LAW OFFICE
2020-05-20TEAS/EMAIL CORRESPONDENCE ENTERED
2020-06-17APPROVED FOR PUB - PRINCIPAL REGISTER
2020-07-01NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2020-07-15NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
2020-07-15NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
2020-07-21PUBLISHED FOR OPPOSITION
2020-07-21OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2020-07-31NOTIFICATION PROCESSED BY IB
2020-10-06REGISTERED-PRINCIPAL REGISTER
2021-01-06FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
2021-01-28GENERIC MADRID TRANSACTION CREATED
2021-01-28GENERIC MADRID TRANSACTION SENT TO IB
2021-03-01FINAL DECISION TRANSACTION PROCESSED BY IB